MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
about
A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasionMicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsMicroRNAs Regulate Mitochondrial Function in Cerebral Ischemia-Reperfusion InjuryThe role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyondA systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcomaAlteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancerDirect Activation of Bax Protein for Cancer TherapyNovel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.The role of microRNAs in glioma initiation and progression.Set9, NF-κB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells.Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells.MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China.Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer RiskAssociation between DNA methylation and multidrug resistance in human glioma SHG-44 cellsDown-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells.Regulation of cancer metastasis by cell-free miRNAs.Nanoscale TiO2 nanotubes govern the biological behavior of human glioma and osteosarcoma cells.Apoptosis and the target genes of microRNA-21.Drug resistance in glioblastoma: a mini reviewmiR-98 and its host gene Huwe1 target Caspase-3 in Silica nanoparticles-treated male germ cellsThe genomic and proteomic content of cancer cell-derived exosomesParaquat Induces Apoptosis through a Mitochondria-Dependent Pathway in RAW264.7 Cells.1800MHz Microwave Induces p53 and p53-Mediated Caspase-3 Activation Leading to Cell Apoptosis In Vitro.Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutationNon-coding RNAs--novel targets in neurotoxicity.The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity.Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathwayTumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas.Insulin deprivation decreases caspase-dependent apoptotic signaling in cultured rat sertoli cells.Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic CholangiocarcinomaNanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes.MicroRNAs as therapeutic targets in chemoresistance.MicroRNA in Human GliomaDown-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1.
P2860
Q24633772-574A5302-25E7-4EF4-9D3D-EB3E54015006Q26747273-8DBFF61F-58DA-4752-9601-74D22852FE13Q26780451-6523E381-A0B8-4395-AA0F-942E4D066E2CQ26851645-5E4106BF-63A6-4AF2-8491-59B8106F3CC0Q28482357-D0D2AD74-93DB-4F9E-B340-0FB2BA44D125Q28541175-37FB000B-5FBC-44FD-B7B9-A58CF96D638BQ30353924-D3C1871F-8682-40C3-B270-D00933BF0EFDQ30413140-5D913C6D-FF74-4443-BB06-961F3758F9DFQ30428370-494E042B-D77D-4640-9318-EDBFA872951FQ33862343-26C2AAD1-DC19-4F47-98B1-BFBA74EA8B3FQ33911224-117A2E4F-AA16-4F34-BB54-9C233D833A68Q33986171-E45F6D37-4688-4843-AF2B-B5DDF6FEF417Q33989118-CC72B8F3-05D9-41D3-8DF0-34C9E75105EEQ34103347-D02CC6BB-2B0A-4B08-8CD1-5A2707DF7583Q34409620-1645A55A-68FC-4F1C-B66E-347D4C60A747Q34478948-6B7011A5-9EEB-4E77-ACCF-BD54F9B78E53Q34494043-0DAA26BA-9C00-4C78-86A7-E67023AC1CEFQ34540841-F5560B46-1969-4BEA-9A4D-802F79A08A87Q34611989-4520CF99-3DFA-4A91-936D-6217B8865FCFQ35034340-B1E7C84F-225F-4AD9-B56A-35E32318D865Q35238567-8FEA25DC-88D3-49F9-ACC1-15BCCF84233FQ35871493-59A8DE08-BD19-4789-9C74-02A0579DF82FQ35899534-30B86F4C-FC82-422C-84A0-2BC27CDA9ABAQ35937877-DC6C6C4D-5A2D-4122-A8BD-8767CA9959A5Q35971555-C49596CA-7B08-49F9-BC20-66FDA1228245Q36015693-9D95E61A-8126-476D-9AD7-A13F42E6D11FQ36149743-8AA9B3ED-3A6B-4E02-924B-A014991FD102Q36276264-97CF86A5-BC78-4DC2-B33A-0BB69103967BQ36292215-91D18543-0BB4-420F-AA68-E308B1A02F49Q36316457-39389154-35FD-4B36-A52F-513FE3F755A4Q36387641-F888A248-759B-4365-8F6F-F5A98C645284Q36545873-D0466367-7A30-477D-AC71-A7A29CFD2BBFQ36633464-249A3E9D-E129-4690-A574-3646D57DEA12Q36651893-13ABA065-6D7E-4E30-871B-D125C1E76CBCQ37280202-7117362D-0B53-4AE8-B343-8471CAECB868Q37296946-410BC186-B6AF-4158-9418-44EBE899137EQ37370429-02C9EF74-F689-41CD-9A53-8AE6EC546156Q37381107-FB2A5D6A-2F48-4F73-B60A-37989AA6F4A7Q37420580-1CA002ED-9DB3-4BD1-ABC0-E048F07333BEQ37457656-2FE1E3E4-1BD1-45A8-A88F-FD94F96D8287
P2860
MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
MiR-21 protected human gliobla ...... ratio and caspase-3 activity.
@en
MiR-21 protected human gliobla ...... ratio and caspase-3 activity.
@nl
type
label
MiR-21 protected human gliobla ...... ratio and caspase-3 activity.
@en
MiR-21 protected human gliobla ...... ratio and caspase-3 activity.
@nl
prefLabel
MiR-21 protected human gliobla ...... ratio and caspase-3 activity.
@en
MiR-21 protected human gliobla ...... ratio and caspase-3 activity.
@nl
P2093
P1433
P1476
MiR-21 protected human gliobla ...... ratio and caspase-3 activity.
@en
P2093
Shuguang Zhang
Tianhong Pan
Zhimin Wang
P304
P356
10.1016/J.BRAINRES.2010.07.009
P407
P577
2010-07-13T00:00:00Z